4

PRIMARY DOCUMENT

Company: ENANTA PHARMACEUTICALS INC
Filed: May 10, 2016
Period of Report: May 10, 2016
Accession Number: 0000908662-16-000524

View Document ↗ View on SEC.gov ↗